Filing Details

Accession Number:
0001127602-10-011602
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-21 13:00:00
Reporting Period:
2010-04-20
Filing Date:
2010-04-21
Accepted Time:
2010-04-21 14:35:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310142 Sensient Technologies Corp SXT Industrial Organic Chemicals (2860) 390561070
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1199081 P Kenneth Manning 777 East Wisconsin Avenue
Milwaukee WI 53202
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-04-20 60,000 $23.19 309,398 No 4 M Direct
Common Stock Disposition 2010-04-20 60,000 $31.15 249,398 No 4 S Direct
Common Stock Disposition 2010-04-20 21,575 $31.16 227,823 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2010-04-20 60,000 $0.00 60,000 $23.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
86,604 2003-12-09 2012-12-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,793 Indirect ESOP
Common Stock 16,371 Indirect Savings Plan
Common Stock 2,000 Indirect Spouse
Common Stock 51,383 Indirect Supplemental Benefit Plan
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $23.00 2005-12-06 2014-12-06 28,396 28,396 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2014-12-06 28,396 28,396 Direct
Footnotes
  1. Exercise of in-the-money stock option that would otherwise expire on 12/9/2012, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $30.90 to $31.71. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. Represents shares held in Issuer's ESOP as of the end of the month immediately preceding this filing.
  5. Represents shares held in Issuer's Savings Plan as of the end of the month immediately preceding this filing.
  6. Represents shares held in Issuer's Supplemental Benefit Plan as of the most recent statement date.
  7. Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.